The analysis from the online database showed that the average expression of S100A8 at the mRNA level in recurrent breast cancer patients was also higher than that in breast cancer patients without relapse, but there was no significant difference between the two groups (Figure 3C). This evidence concerns the gene S100A8 and breast cancer.